We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Smoke signal

13 August 2021 By Dasha Afanasieva

The inhaler maker endorsed a bid from Philip Morris that was 6% above one from Carlyle. Juicier shareholder returns and deeper pockets to invest prevailed over distaste for Big Tobacco. But the noisy debate makes scrutinising deals on broader stakeholder grounds look more normal.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)